Taking place 28^th – 29^th February 2008, PAT & Quality by Design will provide a practical case study based Pan-European forum, bringing together people from across the pharmaceutical industry, regulatory associations, academia and technology providers to discuss how to take PAT forward to capitalise on the benefits. 

It will focus on several topics within this area including the latest thinking on Quality by Design, Data management, risk analysis, different spectroscopic systems, and six sigma.  

PAT & QbD 2008 will build on feedback from the last 4 annual events to deliver an essential learning and networking forum. Industry professionals in Manufacturing, Operations, Analytical & Process Development and Quality Assurance understand the benefits of PAT, and are now striving to effectively implement these strategies.  

As this initiative continues to gain momentum, the agenda will be researched and developed to reflect the latest insights and most recent case studies. Interactive workshops, discussion sessions and extensive networking opportunities ensure an ideal platform for knowledge sharing on the latest technologies, strategies and regulatory clarity. Sign up to be part of this essential and comprehensive forum to help take PAT & QbD to the next level.   

“The conference was attended by leading pharmaceutical decision makers in Europe. The presentations were of high quality and resulted in lively discussions” Hamilton Sunstrand 

“Excellent, practical understanding of the current industry status”
Napp Pharmaceuticals

All New For Pat 2008

Announcing your speaker panel for Pharma IQ’s 5th Annual PAT and Quality by Design 2008

• Claus Mortensen, Medicines Inspector, EMEA PAT Team
• Dr. Theodora Kourti, Senior Technical Director, GlaxoSmithKline
• Michael Schousboe, Principal Scientist, Expert Manufacturing Science and Quality, Novo Nordisk, and member of the ASTM E55 Committee on PAT
• Jay Makwana, Associate Director, Analytical R&D, Pfizer Global R&D
• Marco Barba, Analytical Development Centre of Expertise, Merck Serono
• Dr. J. Axel Zeitler, Department of Chemical Engineering, University of Cambridge
• Chris Driscoll, Director of Operational Excellence, Amgen
• Julian Morris, Professor of Process Control and Co-Director of CPACT
• Graham Cook, Senior Director, Process Knowledge and Quality by Design, Wyeth Pharmaceuticals
• Dr. Joachim Oelichmann, Product Manager Pharma, Buchi
• Christer Karlsson, Gpard Leader, Product and Process Robustness, AstraZeneca
• Fritz Erni, Head of Technology Liaison, Global Quality Operation, Novartis
• David Littlejohn and David Lovett, Centre for Process Analytics and Control Technology (CPACT)
• Jutta Beyer, Principal Scientist, Novartis
• Petter Moree, Director, Online Products, Umetrics
• Ian Clegg, Head of PAT, Pfizer
• Mel Koch, Executive Director, CPAC

Email: enquire@iqpc.co.uk